Further research is needed to address whether the use of RAS inhibitors, including AT1R receptor blockers and ACEis, which up-regulate the ACE2/Ang-(1-7)/MasR axis, may help to mitigate the effects of COVID-19 in male and possibly postmenopausal female hypertensive patients. Here, ACE2 is linked to COVID-19.